"Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease"

Wilhelminenspital Department of Neurology, Vienna

Bendheim Parkinson's and Movement Disorder Center (Mount Sinai Medical Center), New York

Columbia University Medical Center - Neurological Institute, Movement Disorders, New York

SUNY Downstate Medical Center, Department of Neurology, Brooklyn

Jefferson University Hospital Philadelphia, Philadelphia

MedStar Georgetown University Hospital, Washington D.C.

University of Maryland, Baltimore

Johns Hopkins University, Baltimore

Sentara Neuroscience Institute, Virginia Beach

Wake Forest Baptist Health, Winston-Salem

Raleigh Neurology Associates, P.A., Raleigh

Duke University - Movement Disorders Clinic, Durham

Medical University of South Carolina, Charleston

Emory University Department of Neurology, Atlanta

GRU Movement Disorders, Augusta

Centre d'Investigation Clinique, CIC 1436, CHU Purpan, Toulouse

University of Miami, Miller School of Medicine, Miami

Parkinsons Disease and Movement Disorders Center, Boca Raton

USF Parkinson's Disease and Movement Disorder Center, Tampa

Suncoast Neuroscience Associates Inc., St. Petersburg

Parkinson's Disease Treatment Center of Southwest Florida, Port Charlotte

University of Alabama Birmingham, Birmingham

University of Kentucky, Lexington

The Ohio State University Wexner Medical Center, Columbus

UT Gardner-McMaster Parkinson's Center, Toledo

Cleveland Clinic, Cleveland

St. Josef-Hospital, Klinikum der Ruhr-Universitaet-Bochum, Neurologische Klinik, Bochum

University of Cincinnati, Cincinnati

Henry Ford Hospital, West Bloomfield

QUEST Research Institute, Farmington Hills

Michigan State University - Dept. of Neurology, East Lansing

University of Iowa Dept. of Neurology, Iowa City

Park Nicolet Institute - Stuthers Parkinson's Center, Golden Valley

NorthShore Neurological Institute B043D, Glenview

Ospedali Riuniti di Ancona, Ancona

Central DuPage Hospital - Neurodegenerative Clinic - Movement Disorders Center, Winfield

Northwestern University, Chicago

Rush University Medical Center, Chicago

Aging Research Center, Ce.S.I. University Foundation, Chieti-Pescara Behavioural Neurology & Movement Disorders Unit, Chieti

Kansas University Medical Center-Department of Neurology, Kansas City

Clinical Trials, Inc., Little Rock

The Movement Disorder Clinic of Oklahoma, Tulsa

East Texas Medical Center, Tyler

Houston Methodist Neurological Institute, Houston

University of Colorado School of Medicine, Aurora

Muhammed Ali Parkinson and Movement Disorder Center/Barrow Neurological Institute, Phoenix

Movement Disorders Center of Arizona, Scottsdale

Universitätsklinikum Ulm Neurologisches Studienzentrum im RKU, Ulm

Keck Medical Center at USC, Los Angeles

UC Irvine Health Gottschalk Medical Plaza, Irvine

The Parkinson's and Movement Disorder Institute, Fountain Valley

Evergreen Health, Kirkland

Swedish Neuroscience Research, Seattle

University of Virginia Adult Neurology, Charlottesville

Medical University Innsbruck Neurology Department, Innsbruck

UHN Toronto Western Hospital, Toronto

Centro Ricerche San Raffaele, Cassino

IRCCS San Raffaele Pisana - Clinical Trial Center, Rome

Hospital Clinic de Barcelona, Barcelona

Hospital Universitari General de Catalunya, Sant Cugat Del Vallés

Kings College, The Maurice Wohl Neuroscience Institute, London

Manchester University, Salford

Newcastle University, Newcastle upon Tyne

Forth Valley Royal Hospital, Larbert

Fairfield General Hospital, Bury

Royal Devon & Exeter NHS Foundation Trust, Exeter

Queen Elizabeth University Hospital, Glasgow

Leeds Teaching Hospitals NHS Trust, Leeds

Imperial College Healthcare Trust NHS, London

Plymouth University, Plymouth